BackHarvard Apparatus Regenerative Technology Overview

Harvard Apparatus Regenerative Technology Profit Margin

Valuation check: HRGN's profit margin is -750.41%, below the Healthcare sector average of 17.63%.

Get informed when a big investor buys or sells

+ Follow

Quarterly Profit Margin

N/A

As of Sep 2026

Annual Profit Margin (TTM)

-750.41%

Trailing 12 months ending Sep 2026

Average Profit Margin (Comparison Companies)

Loading

Profit Margin History

Loading

Profit Margin Comparison

Loading

Annual Profit Margin Growth Rate (%)

Loading

Harvard Apparatus Regenerative Technology (HRGN) FAQ

As of the most recent data (September 2026), HRGN shows a profit margin of -750.41%. That is below the Healthcare sector average of 17.63%. Scroll down for historical charts and peer comparison views.

The Healthcare sector average profit margin is about 17.63%. Harvard Apparatus Regenerative Technology is at -750.41%, which is lower that average. That is roughly 4356.8% below the sector mean. Use the comparison chart on this page to see how HRGN stacks up against individual peers as well.

Check the historical chart to see whether HRGN's profit margin is trending up or down. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Harvard Apparatus Regenerative Technology with peers to see if the move is company-specific or sector-wide.

Besides this profit margin page, Stockcircle has Harvard Apparatus Regenerative Technology's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect profit margin (currently -750.41%) with ownership activity and broader fundamentals.

The Healthcare average profit margin is about 17.63%, while HRGN is at -750.41%. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.